In 2021, there were around *** deaths per 100,000 population due to chronic obstructive pulmonary disease (COPD) in Oceania. This was the highest rate of death due to COPD worldwide. Globally, there were around ** COPD deaths per 100,000 population in 2021.

Mortality from bronchitis and emphysema and other chronic obstructive pulmonary disease (ICD-10 J40-J44 equivalent to ICD-9 490-492, 496) To reduce deaths from bronchitis, emphysema and other chronic obstructive pulmonary disease. Legacy unique identifier: P00177

In 2021, there were around 1.32 million deaths in East Asia due to chronic obstructive pulmonary disease (COPD). That year, there were a total of 3.72 million deaths due to COPD.

An analysis of death certificate data from 1999 and 2019 in the United States, revealed a decrease in the rate of deaths related to chronic obstructive pulmonary disease (COPD) among men aged 25 years and older in all regions of the United States. In 1999, the rate of deaths related to COPD among men in the South was 92.4 per 100,000 population, while in 2019 this death rate was 69. This graph shows the rate of deaths related to COPD among U.S. men aged 25 years and above in 1999 and 2019, by region.

An analysis of death certificate data from 1999 and 2019 in the United States, revealed an increase in the rate of deaths related to chronic obstructive pulmonary disease (COPD) among women aged 25 years and older in the Midwest and the South. In 1999, the rate of deaths related to COPD among women in the South was **** per 100,000 population, while in 2019 this death rate was ****. This graph shows the rate of deaths related to COPD among U.S. women aged 25 years and above in 1999 and 2019, by region.

In 2021, the death rate from chronic obstructive pulmonary disease (COPD) among women aged 45 years and older was around ** per 100,000 population, while the death rate for men was about *** per 100,000 population. This statistic shows the age-adjusted death rate from COPD among U.S. adults aged 45 years and older from 1999 to 2021, by gender.

An analysis of death certificate data from 1999 and 2019 in the United States, revealed a decrease in the rate of deaths related to chronic obstructive pulmonary disease (COPD) among men aged 25 years and older in micropolitan areas. In 1999, the rate of deaths related to COPD among men in micropolitan areas was ***** per 100,000 population, while in 2019 this death rate was **. This graph shows the rate of deaths related to COPD among U.S. men aged 25 years and above in 1999 and 2019, by urban-rural status.

An analysis of death certificate data from 1999 and 2019 in the United States, revealed an increase in the rate of deaths related to chronic obstructive pulmonary disease (COPD) among women aged 25 years and older in micropolitan areas. In 1999, the rate of deaths related to COPD among women in micropolitan areas was 56.8 per 100,000 population, while in 2019 this death rate was 71.3. This graph shows the rate of deaths related to COPD among U.S. women aged 25 years and above in 1999 and 2019, by urban-rural status.

This statistic shows the rate of death from Chronic Obstructive Pulmonary Disease (COPD) in the U.S. in 2015, by urban-rural status. In that year, around ** people per 100,000 population in small metropolitan counties died from COPD.

In 2023, it was estimated that almost 10 percent of those aged 65 years and older in the United States had been diagnosed with COPD, emphysema, or chronic bronchitis. This statistic shows the percentage of U.S. adults aged 65 years and older who had ever been told by a doctor or other health professional they had COPD, emphysema, or chronic bronchitis from 2019 to 2023.

This data shows premature deaths (Age under 75) from Respiratory Disease, numbers and rates by gender, as 3-year range.

Smoking is the major cause of chronic obstructive pulmonary disease (COPD), one of the major Respiratory diseases. COPD (which includes chronic bronchitis and emphysema) results in many hospital admissions. Respiratory diseases can also be caused by environmental factors (such as pollution, or housing conditions) and influenza. Respiratory disease mortality rates show a socio-economic gradient.

Directly Age-Standardised Rates (DASR) are shown in the data, where numbers are sufficient, so that death rates can be directly compared between areas. The DASR calculation applies Age-specific rates to a Standard (European) population to cancel out possible effects on crude rates due to different age structures among populations, thus enabling direct comparisons of rates.

A limitation on using mortalities as a proxy for prevalence of health conditions is that mortalities may give an incomplete view of health conditions in an area, as ill-health might not lead to premature death.

Data source: Office for Health Improvement and Disparities (OHID) Public Health Outcomes Framework (PHOF) indicator 4.07i. This data is updated annually.

The number of deaths from obstructive pulmonary disease per 100,000 inhabitants in Spain in 2022 was highest in the autonomous community of Ceuta. In that year, the mortality rate from COPD in that region amounted to ***** deaths per 100,000 inhabitants. The Balearic Islands and Murcia followed, with a COPD mortality rate of ***** and ***** people per 100,000 population, respectively.

In 2020, it was estimated that around 10.6 percent of the world population had chronic obstructive pulmonary disease (COPD). Over the coming decades, the prevalence of COPD is expected to decrease. This statistic shows the prevalence of COPD worldwide in 2020 and projections to 2050.

Background Chronic obstructive pulmonary disease (COPD) has been becoming a great public health concern worldwide. However, few studies employed retrospective and predictive approaches to assess the global burden of COPD. Thus, this study aimed to estimate the global burden of COPD by age, gender and socioeconomic status in the past decades of this century, and then make a prediction to 2030.Methods The data analyzed in this study were obtained from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021. The outcome variables, the disease burden of COPD, referred to absolute numbers of COPD case and age-standardized rates (ASRs) per 100,000 individuals per year. The temporal trends from 2000 to 2021 were examined using Joinpoint models. And, Bayesian age-period-cohort models were introduced to project the burden of COPD to 2030. Finally, a decomposition analysis was conducted to reveal the contributions of aging, population growth and epidemiological changes to trends in COPD burden.Results From 2000 to 2021, absolute numbers of incident cases, prevalent cases, deaths and disability-adjusted life years (DALYs) for COPD continued to increase at the global level. However, ASRs of incidence, prevalence, deaths and DALYs decreased, and, moreover, such a declining trend would continue to 2030. Additionally, in 2021, the ASR of COPD burden was higher in males than females, and the rate increased with age among global population. Interestingly, the disease burden varied significantly across different regions, with a comparatively high burden in low socio-demographic index region. Decomposition analysis revealed that the increasing burden of COPD was primarily driven by rapid aging and population growth.Conclusions The global ASRs of COPD burden would continue to decline, but the crude burden would remain increasing to 2030, which was mainly attributed to population aging and growth. This study has significant public health implications that precision intervention strategies shall be initiated for population-based campaigns against COPD with consideration of residents’ age, gender and area as well as economic development.

Deaths from bronchitis and emphysema, classified by underlying cause of death. Directly age-Standardised Rates (DSR) per 100,000 population Source: Office for National Statistics (ONS) Publisher: Information Centre (IC) - Clinical and Health Outcomes Knowledge Base Geographies: Local Authority District (LAD), Government Office Region (GOR), National, Strategic Health Authority (SHA) Geographic coverage: England Time coverage: 2005-07, 2007 Type of data: Administrative data

Background: Chronic obstructive pulmonary disease (COPD) is among leading causes of death globally. Exposure to outdoor pollution is an important cause for increased mortality and morbidity. This study presents a systemic review regarding the impact of outdoor pollution on COPD mortality in South Asia and China.

Methods: A systematic search was conducted from 1990 to June 30^th 2020 in English electronic databases: PubMed, Google Scholar and CDSR (Cochrane Database of Systematic Reviews) following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The following terms were used: Chronic Obstructive Pulmonary disease OR COPD OR Chronic Bronchitis OR Emphysema OR COPD Deaths OR Chronic Obstructive Lung Disease OR Airflow Obstruction OR Chronic Airflow Obstruction OR Airflow Obstruction, Chronic OR Bronchitis, Chronic AND Mortality OR Death OR Deceased AND Outdoor pollution, ambient pollution was conducted.

Results: Out of 1899 papers screened only 17 were found eligible to be included. Subjects with COPD exposed to higher levels of outdoor air pollution had a 49% higher risk of death as compared to COPD subjects exposed to lower levels of outdoor air pollution. When taking common air pollutants individually into consideration, PM10 had an odds ratio (OR) of 1.99 respectively at CI 95%, whereas SO2 had OR of 1.8 at 95% CI, and NO2 had an OR of 1.23 OR at 95% CI. These values suggest that there is an effect of outdoor pollution on COPD but not to a significant level.

Conclusion: Despite heterogeneity across selected studies, individuals exposed to outdoor pollutants were found to be at risk of COPD mortality. Though it appears to have risk, COPD mortality was not significantly associated with outdoor pollutants. Controlling air pollution can substantially decrease the risk of COPD in South Asia and China. Further researches including more prospective and longitudinal studies are urgently needed in COPD sub-groups.

Background: We aimed to estimate the incidence, mortality, disability-adjusted life years (DALYs) for chronic obstructive pulmonary disease (COPD) in 204 countries and territories. We examined the variations in these trends by country, gender, age group, and sociodemographic index (SDI).Methods: We calculated the estimated annual percentage changes (EAPCs) to assess temporal trends in the age-standardized incidence rate, age-standardized mortality rate, and age-standardized DALYs of COPD from 1990 to 2019.Results: From 1990 to 2019, the COPD incidence and COPD-associated deaths and DALYs increased worldwide by 86%, 30%, and 26%, respectively. From 1990 to 2019, the global age-standardized incidence rate (EAPC, −0.11; 95% confidence interval (CI), −0.25 to 0.04), age-standardized mortality rate (EAPC, −2.10; 95% CI, −2.19 to −2.00), and age-standardized DALYs (EAPC, −1.87; 95% CI, −1.94 to −1.81) of COPD decreased. The age-standardized incidence of COPD increased most in areas with high SDI (EAPC 0.56). The largest increases in the age-standardized incidence rate of COPD were recorded in High-income North America (EAPC, 1.41), Southern Latin America (EAPC, 0.29), and North Africa and the Middle East (EAPC, 0.09). The three countries that recorded the largest increases in COPD incidence from 1990 to 2019 were the United States of America (EAPC, 1.51), Saudi Arabia (EAPC, 1.17), and Oman (EAPC, 1.10).Conclusion: Despite the decreased burden of COPD globally from 1990 to 2019, the age-standardized incidence rate of COPD increased in areas with high SDI, High-income North America, Southern Latin America, North Africa, and the Middle East.

Chronic obstructive pulmonary disease (COPD) causes a high disease burden among the elderly worldwide. In Taiwan, the long-term temporal trend of COPD mortality is declining, but the geographical disparity of the disease is not yet known. Nationwide COPD age-adjusted mortality at the township level during 1999–2007 is used for elucidating the geographical distribution of the disease. With an ordinary least squares (OLS) model and geographically weighted regression (GWR), the ecologic risk factors such as smoking rate, area deprivation index, tuberculosis exposure, percentage of aborigines, density of health care facilities, air pollution and altitude are all considered in both models to evaluate their effects on mortality. Global and local Moran’s I are used for examining their spatial autocorrelation and identifying clusters. During the study period, the COPD age-adjusted mortality rates in males declined from 26.83 to 19.67 per 100,000 population, and those in females declined from 8.98 to 5.70 per 100,000 population. Overall, males’ COPD mortality rate was around three times higher than females’. In the results of GWR, the median coefficients of smoking rate, the percentage of aborigines, PM10 and the altitude are positively correlated with COPD mortality in males and females. The median value of density of health care facilities is negatively correlated with COPD mortality. The overall adjusted R-squares are about 20% higher in the GWR model than in the OLS model. The local Moran’s I of the GWR’s residuals reflected the consistent high-high cluster in southern Taiwan. The findings indicate that geographical disparities in COPD mortality exist. Future epidemiological investigation is required to understand the specific risk factors within the clustering areas.

Death rate has been age-adjusted by the 2000 U.S. standard population. Single-year data are only available for Los Angeles County overall, Service Planning Areas, Supervisorial Districts, City of Los Angeles overall, and City of Los Angeles Council Districts.Chronic obstructive pulmonary disease (COPD) refers to a group of diseases, including emphysema and chronic bronchitis, that create airflow blockages in the lungs. Exposure to tobacco smoke is an important risk factor for COPD. Cities and communities can take an active role in curbing tobacco use and reducing COPD by adopting policies to regulate tobacco retail; reducing exposure to secondhand smoke in outdoor public spaces, such as parks, restaurants, or in multi-unit housing; and improving access to tobacco cessation programs and other preventive services.For more information about the Community Health Profiles Data Initiative, please see the initiative homepage.

BackgroundChronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality globally, with significant disparities in disease burden across countries and socioeconomic regions. Despite advancements in public health, the global burden of COPD remains substantial, particularly in low- and middle-income countries. This study aims to provide a comprehensive analysis of global, regional, and national trends in COPD-related prevalence, deaths, and disability-adjusted life years (DALYs) from 1990 to 2021 using an age-period-cohort (APC) model.MethodsData from the Global Burden of Disease Study 2021 were analyzed for 204 countries and territories, stratified by five Sociodemographic Index (SDI) levels. An APC model was employed to assess the temporal effects of age, time periods, and birth cohorts on COPD burden. Trends in prevalence, deaths, and DALYs were evaluated through metrics such as Net Drift, Local Drift, and risk ratios.ResultsGlobally, from 1990 to 2021, the age-standardized rates of COPD demonstrated a decline of −1.46% (95% UI: −3.36 to 0.39%) in prevalence, −37.12% (95% UI: −43.37% to −27.68%) in deaths, and −36.98% (95% UI: −42.37% to −28.54%) in DALYs. After adjusting for age and cohort effects, the annual changes were −0.35% (95% UI: −0.39% to −0.32%) in prevalence, −3.87% (95% UI: −4.00% to −3.74%) in deaths, and − 2.95% (95% UI: −3.02% to −2.89%) in DALYs. Notably, in middle, low-middle, and low SDI regions, the age-standardized prevalence rates in 2021 showed an increase compared to 1990, with respective changes of 4.03% (95% UI: 2.00–5.89%), 0.13% (95% UI: −2.90 to 2.84%), and 6.71% (95% UI: 4.25–8.91%). However, age-standardized deaths and DALYs significantly decreased across all five SDI regions. From an age effect perspective, globally, over 50% of COPD prevalence is concentrated among individuals aged 65 years and older, particularly in middle, low-middle, and high-middle SDI regions. COPD-related deaths and DALYs have shown a declining trend across all age groups. Globally, the period effect indicates that earlier periods were associated with a higher burden of disease, while cohort effects highlight that birth cohorts around 1920 had a particularly pronounced impact on the COPD burden. Both period and cohort effects exhibited notable heterogeneity across different SDI regions and countries,ConclusionThe prevalence of COPD remains concerning. Compared to 1990, the global prevalence of COPD in 2021 showed a stable or slightly increasing trend, with over half of the countries experiencing an annual increase in prevalence during the 1990–2021 period. Global mortality and DALYs associated with COPD showed a notable decline in 2021 compared to 1990. However, this trend exhibited significant heterogeneity across countries and regions, likely linked to differences in socioeconomic development. Countries in the high-middle and middle SDI regions were found to be more affected by period effects. From an age effect perspective, population aging has undoubtedly exacerbated the COPD burden. Regarding cohort effects, earlier birth cohorts demonstrated a stronger contribution to the increasing disease burden. While Higher levels of socioeconomic development can mitigate the adverse effects associated with earlier birth cohorts.